CFO Jeffrey Church retiring June 1; David Gaiero appointed as successor

Imunon, Inc.

Jeffrey Church to retire as CFO effective June 1, 2024; will serve as consultant through Dec 31, 2024.
Church receives retirement bonus of $428,615; monthly consulting retainer of $10,000 plus $250/hr over 40 hrs.
David Gaiero appointed CFO via Monomoy Advisors; monthly fee of $35,000 starting June 1, 2024.
Gaiero is a partner at Monomoy, served as CFO of Cyteir Therapeutics and interim CFO at Wave Life Sciences.
Church's vested stock options extended to original expiration; unvested options treated per plan.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeffrey Church

Chief Financial Officer

IMNN · Imunon, Inc.

Effective: 2024-06-01
Successor: David Gaiero
Filed: May 20, 2024, 7:59 PM ET

On May 15, 2024, Jeffrey Church informed Imunon, Inc. (the “Company”) of his intent to retire from all positions with the Company

Appointed

David Gaiero

Chief Financial Officer

IMNN · Imunon, Inc.

Effective: 2024-06-01
Filed: May 20, 2024, 7:59 PM ET

effective June 1, 2024, the Company appointed David Gaiero to serve as the Company’s new Chief Financial Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Church retired as Chief Financial Officer at Imunon, Inc..

Action: retired
Role: Chief Financial Officer

Exact text from the filing

On May 15, 2024, Jeffrey Church informed Imunon, Inc. (the “Company”) of his intent to retire from all positions with the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Gaiero was appointed as Chief Financial Officer at Imunon, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

effective June 1, 2024, the Company appointed David Gaiero to serve as the Company’s new Chief Financial Officer

View on SEC.gov

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-020543

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.